Speed to market and development efficiency have long been drivers in the pharmaceutical industry but these factors have become more important than ever, given the changing landscape of markets. This “need for speed” is particularly important as accelerated development timelines and accelerated approval mechanisms become more common. The timely manufacture and delivery of drug product for clinical trials becomes essential, particularly for complex molecules such as high-potency active pharmaceutical ingredients (HPAPIs).
- Important factors to consider in meeting accelerated timelines
- The importance of choosing the right partner to ensure an efficient, focused development program